Literature DB >> 31327262

Selective Renal Denervation Guided by Renal Nerve Stimulation in Canine.

Hang Liu1, Weijie Chen1, Yinchuan Lai1, Huaan Du1, Zihao Wang1, Yanping Xu1, Zhiyu Ling1, Jinqi Fan1, Peilin Xiao1, Bo Zhang1, Jie Wang2, Laxman Gyawali1, Bernhard Zrenner3, Kamsang Woo4, Yuehui Yin1.   

Abstract

Renal nerve stimulation (RNS) can result in substantial blood pressure (BP) elevation, and the change was significantly blunted when repeated stimulation after ablation. However, whether RNS could provide a meaningful renal nerve mapping for identification of optimal ablation targets in renal denervation (RDN) is not fully clear. Here, we compared the antihypertensive effects of selective RDN guided by two different BP responses to RNS and explored the nerve innervations at these sites in Kunming dogs. Our data indicated that ablation at strong-response sites showed a more systolic BP-lowering effect than at weak-response sites (P=0.002), as well as lower levels of tyrosine hydroxylase and norepinephrine in kidney and a greater reduction in plasma norepinephrine (P=0.004 for tyrosine hydroxylase, P=0.002 for both renal and plasma norepinephrine). Strong-response sites showed a greater total area and mean number of renal nerves than weak-response sites (P=0.012 for total area and P<0.001 for mean number). Systolic BP-elevation response to RNS before RDN and blunted systolic BP-elevation to RNS after RDN were correlated with systolic BP changes at 4 weeks follow-up (R=0.649; P=0.012 and R=0.643; P=0.013). Changes of plasma norepinephrine and renal norepinephrine levels at 4 weeks were also correlated with systolic BP changes at 4 weeks (R=0.837, P<0.001 and R=0.927, P<0.001). These data suggest that selective RDN at sites with strong BP-elevation response to RNS could lead to a more efficient RDN. RNS is an effective method to identify the nerve-enriched area during RDN procedure and improve the efficacy of RDN.

Entities:  

Keywords:  blood pressure; denervation; dogs; hypertension; kidney

Mesh:

Substances:

Year:  2019        PMID: 31327262     DOI: 10.1161/HYPERTENSIONAHA.119.12680

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

Review 1.  Sympathetic Nervous System Contributions to Hypertension: Updates and Therapeutic Relevance.

Authors:  Leon J DeLalio; Alan F Sved; Sean D Stocker
Journal:  Can J Cardiol       Date:  2020-03-06       Impact factor: 5.223

2.  Rationale and Design of Sympathetic Mapping/Ablation of Renal Nerves Trial (SMART) for the Treatment of Hypertension: a Prospective, Multicenter, Single-Blind, Randomized and Sham Procedure-Controlled Study.

Authors:  Jie Wang; Ningling Sun; Junbo Ge; Hong Jiang; Yuehui Yin; Minglong Chen; Yue Wang; Chen Yao; Xiaoyan Yan; Paul A Sobotka; Yong Huo
Journal:  J Cardiovasc Transl Res       Date:  2022-08-30       Impact factor: 3.216

3.  Safety and efficacy of renal denervation in patients with heart failure with reduced ejection fraction (HFrEF): A systematic review and meta-analysis.

Authors:  Zhiqiu Xia; Li Han; Peter R Pellegrino; Alicia M Schiller; Logan D Harrold; Robert L Lobato; Steven J Lisco; Irving H Zucker; Han-Jun Wang
Journal:  Heliyon       Date:  2022-01-31

Review 4.  Present Evidence of Determinants to Predict the Efficacy of Renal Denervation.

Authors:  Hao Zhou; Yanping Xu; Weijie Chen; Liang Wang; Huaan Du; Hang Liu; Zhiyu Ling; Yuehui Yin
Journal:  Int J Hypertens       Date:  2022-08-12       Impact factor: 2.434

Review 5.  The role of renal nerve stimulation in percutaneous renal denervation for hypertension: A mini-review.

Authors:  Hui-Chun Huang; Hao-Min Cheng; Yook-Chin Chia; Yan Li; Huynh Van Minh; Saulat Siddique; Apichard Sukonthasarn; Jam Chin Tay; Yuda Turana; Narsingh Verma; Kazuomi Kario; Tzung-Dau Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-09       Impact factor: 2.885

Review 6.  Renal Sympathetic Denervation for Hypertension.

Authors:  Kenneth Guber; Ajay J Kirtane
Journal:  Kidney Int Rep       Date:  2022-07-14

Review 7.  Device-Based Sympathetic Nerve Regulation for Cardiovascular Diseases.

Authors:  Le Li; Zhao Hu; Yulong Xiong; Yan Yao
Journal:  Front Cardiovasc Med       Date:  2021-12-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.